» Articles » PMID: 25375158

The Central Nervous System As Target of Bacillus Anthracis Toxin Independent Virulence in Rabbits and Guinea Pigs

Overview
Journal PLoS One
Date 2014 Nov 7
PMID 25375158
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Infection of the central nervous system is considered a complication of Anthrax and was reported in humans and non-human primates. Previously we have reported that Bacillus anthracis possesses a toxin-independent virulent trait that, like the toxins, is regulated by the major virulence regulator, AtxA, in the presence of pXO2. This toxin-independent lethal trait is exhibited in rabbits and Guinea pigs following significant bacteremia and organ dissemination. Various findings, including meningitis seen in humans and primates, suggested that the CNS is a possible target for this AtxA-mediated activity. In order to penetrate into the brain tissue, the bacteria have to overcome the barriers isolating the CNS from the blood stream. Taking a systematic genetic approach, we compared intracranial (IC) inoculation and IV/SC inoculation for the outcome of the infection in rabbits/GP, respectively. The outstanding difference between the two models is exhibited by the encapsulated strain VollumΔpXO1, which is lethal when injected IC, but asymptomatic when inoculated IV/SC. The findings demonstrate that there is an apparent bottleneck in the ability of mutants to penetrate into the brain. Any mutant carrying either pXO1 or pXO2 will kill the host upon IC injection, but only those carrying AtxA either on pXO1 or in the chromosome in the background of pXO2 can penetrate into the brain following peripheral inoculation. The findings were corroborated by histological examination by H&E staining and immunofluorescence of rabbits' brains following IV and IC inoculations. These findings may have major implications on future research both on B. anthracis pathogenicity and on vaccine development.

Citing Articles

Closing the Gaps: Testing the Efficacy of Carbapenem and Cephalosporin Treatments of Late-Stage Anthrax in Rabbits.

Sittner A, Bar-David E, Glinert I, Ben-Shmuel A, Schlomovitz J, Levy H Pathogens. 2024; 13(11).

PMID: 39599489 PMC: 11597137. DOI: 10.3390/pathogens13110936.


Doxycycline, levofloxacin, and moxifloxacin are superior to ciprofloxacin in treating anthrax meningitis in rabbits and NHP.

Ben-Shmuel A, Glinert I, Sittner A, Bar-David E, Schlomovitz J, Levy H Antimicrob Agents Chemother. 2024; 68(6):e0161023.

PMID: 38687017 PMC: 11620489. DOI: 10.1128/aac.01610-23.


Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.

Bradley J, Bulitta J, Cook R, Yu P, Iwamoto C, Hesse E Clin Infect Dis. 2024; 78(6):1451-1457.

PMID: 38412060 PMC: 11175673. DOI: 10.1093/cid/ciae093.


Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.

Kennedy J, Bulitta J, Chatham-Stephens K, Person M, Cook R, Mongkolrattanothai T Clin Infect Dis. 2022; 75(Suppl 3):S379-S391.

PMID: 36251546 PMC: 9649436. DOI: 10.1093/cid/ciac591.


Evaluation of a Frozen Micro-Agar Plates of MAPt Antibiotic Susceptibility Test for Enhanced Bioterror Preparedness.

Rotem S, Shifman O, Aloni-Grinstein R Antibiotics (Basel). 2022; 11(5).

PMID: 35625224 PMC: 9137970. DOI: 10.3390/antibiotics11050580.


References
1.
Hanczaruk M, Reischl U, Holzmann T, Frangoulidis D, Wagner D, Keim P . Injectional anthrax in heroin users, Europe, 2000-2012. Emerg Infect Dis. 2014; 20(2):322-3. PMC: 3901468. DOI: 10.3201/eid2002.120921. View

2.
Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

3.
Ebrahimi C, Kern J, Sheen T, Ebrahimi-Fardooee M, Van Sorge N, Schneewind O . Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. J Bacteriol. 2009; 191(23):7165-73. PMC: 2786561. DOI: 10.1128/JB.00903-09. View

4.
Yoong P, Schuch R, Nelson D, Fischetti V . PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol. 2006; 188(7):2711-4. PMC: 1428399. DOI: 10.1128/JB.188.7.2711-2714.2006. View

5.
Ariel N, Zvi A, Grosfeld H, Gat O, Inbar Y, Velan B . Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun. 2002; 70(12):6817-27. PMC: 133087. DOI: 10.1128/IAI.70.12.6817-6827.2002. View